Quantbot Technologies LP Silverback Therapeutics, Inc. Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	N/A	2,100 New	2,100 $0
Q2 2022 Aug 09, 2022	SELL	$2.9 - $4.44 $15,720 - $24,069	-5,421 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.51 - $6.74 $8,775 - $16,850	-2,500 Reduced 31.56%	5,421 $19,000
Q4 2021 Feb 11, 2022	BUY	$6.03 - $11.67 $47,763 - $92,438	7,921 New	7,921 $52,000

122

61.4M

1.37M

83.8K

Ticker SBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,473,800
Description
Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.